Question · Q4 2025
Jeffrey Zekauskas from JPMorgan asked if the projected lower volumes in both segments for the upcoming year imply that inventories are unlikely to grow. He further probed whether the company expects to utilize working capital in 2026. Regarding plant nutrition, Mr. Zekauskas questioned why volumes were pulled forward into 2025 and the extent of this pull-forward, also asking why the base case EBITDA projection for 2026 isn't higher given a strong second half in 2025.
Answer
Peter Feldman, CFO, stated that the company continues to align inventories and production levels with demand. Edward Dowling, President and CEO, emphasized careful inventory management with an objective to reduce cash and retire debt, indicating no plans to build inventory. Ben Nichols, Chief Commercial Officer, explained that inventory management has two timeframes, with confidence in alignment through March, and future adjustments based on winter conditions. For plant nutrition, Mr. Nichols attributed pulled-forward volumes to market behavior and Ogden's production stability, noting it was a significant but unquantified portion. He added that the primary reason for the 2026 EBITDA projection is the anticipated price upside in the P&L.
Ask follow-up questions
Fintool can predict
CMP's earnings beat/miss a week before the call